Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.34 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28201423 | 0.98 | TDP1 (0.46) | TDP1CAMK2AEPHX2TSHRVCAM1 | |
| SCHEMBL934152 | 0.93 | TDP1 (0.50) | TDP1EPHX2TSHRVCAM1HDAC1 | |
| SCHEMBL16323750 | 0.91 | TDP1 (0.53) | TDP1EPHX2TSHRVCAM1HDAC1 | |
| SCHEMBL17296020 | 0.91 | TDP1 (0.53) | TDP1EPHX2TSHRVCAM1HDAC1 | |
| SCHEMBL3988979 | 0.91 | TDP1 (0.53) | TDP1EPHX2TSHRVCAM1HDAC1 | |
| SCHEMBL25168218 | 0.91 | TDP1 (0.53) | TDP1EPHX2TSHRVCAM1HDAC1 | |
| SCHEMBL8507410 | 0.91 | TDP1 (0.53) | TDP1EPHX2TSHRVCAM1HDAC1 | |
| SCHEMBL8033386 | 0.91 | TDP1 (0.53) | TDP1EPHX2TSHRVCAM1HDAC1 | |
| SCHEMBL22029385 | 0.91 | TDP1 (0.53) | TDP1EPHX2TSHRVCAM1HDAC1 | |
| SCHEMBL31240235 | 0.91 | TDP1 (0.53) | TDP1EPHX2TSHRVCAM1HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119930678-A | Methoxyphos hapten, complete antigen, antibody and preparation method and application thereof | 深圳市计量质量检测研究院 | 2025-05-06 | — | — | CN | claimed |
| CN-106478591-B | A kind of method for splitting of Atorvastatin condensation product intermediate | 北京嘉林药业股份有限公司 | 2018-11-13 | — | — | CN | claimed |
| US-9957214-B2 | Multifunctional radical quenchers | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2018-05-01 | — | — | US | claimed |
| US-20150274628-A1 | MULTIFUNCTIONAL RADICAL QUENCHERS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2015-10-01 | — | — | US | claimed |
| EP-2906207-A1 | MULTIFUNCTIONAL RADICAL QUENCHERS | Arizona Board of Regents on behalf of Arizona State University (US) | 2015-08-19 | — | — | EP | claimed |
| WO-2014059158-A1 | MULTIFUNCTIONAL RADICAL QUENCHERS | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AN ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2014-04-17 | — | — | WO | claimed |
| CN-101248054-B | Thiazole derivatives and use thereof | MERCK SERONO SA | 2012-05-09 | — | — | CN | claimed |
| CN-101248054-A | Thiazole derivatives and use thereof | SERONO LAB (CH) | 2008-08-20 | — | — | CN | claimed |
| EP-0454501-B1 | Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides | SANKYO CO (JP) | 2001-09-05 | — | — | EP | claimed |
| EP-0839812-A1 | Preparation of benzylthiazolidine derivatives | Sankyo Company Limited (JP) | 1998-05-06 | — | — | EP | claimed |
| EP-0454501-A2 | Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides | Sankyo Company Limited (JP) | 1991-10-30 | — | — | EP | claimed |
| JP-10045672-A | — | — | None | — | — | JP | disclosed |
| EP-4003988-B1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | SERVIER LAB (FR) | 2026-05-20 | — | — | EP | disclosed |
| EP-4727537-A2 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | Adaxion Therapeutics, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4719486-A1 | CONJUGATES AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | disclosed |
| EP-0620003-A1 | VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| CN-1090278-A | Blood vessel tension peptide protoenzyme inhibitor-N-(2-amino-2-oxygen ethyl) succinic diamide derivative | BIO MEGA BOEHRINGER INGELHEIM (CA) | 1994-08-03 | — | — | CN | disclosed |
| WO-1994005627-A1 | HYDROXAMIC ACID-BASED BIFUNCTIONAL CHELATING COMPOUNDS | UAB RESEARCH FOUNDATION (US) | 1994-03-17 | — | — | WO | disclosed |
| WO-1994000119-A1 | AMINOBUTANOIC ACID COMPOUNDS HAVING METALLOPROTEASE INHIBITING PROPERTIES | GLAXO INC. (US) | 1994-01-06 | — | — | WO | disclosed |
| EP-0454501-A2 | Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides | Sankyo Company Limited (JP) | 1991-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150274628-A1 | MULTIFUNCTIONAL RADICAL QUENCHERS | SQOR, UQCRC1, PRDX5 | TDP1 392/4885CAMK2A 4120/4885EPHX2 2040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.